newsfilter
← Latest News
Business Wire·

Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability

Healthcare Providers, Healthcare Settings, and Participating Pharmacies Can Now Begin Required Training and Certification in Preparation for MIUDELLA’s Launch Later This Year Organon (NYSE:OGN), a global healthcare